FOLH1 and nonpapillary renal cell carcinoma: Two of the included studies provided a direct comparison of PSMA PET/CT (18F-DCFPyL) and conventional imaging in metastatic ccRCC and support a higher detection rate of PSMA PET/CT, with a pooled detection rate of 0.92 (95% CI, 0.76–0.97) versus 0.63 (95% CI, 0.50–0.74), respectively (17,19).